Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AgfiledCriticalBayer Schering Pharma Ag
Priority to CU20100023ApriorityCriticalpatent/CU23605A3/en
Publication of CU23605A3publicationCriticalpatent/CU23605A3/en
Para controlar la ingesta de medicamentos que están presentes en forma de obleas, se crea un dispositivo que es apropiado para conservar y poner a disposición este tipo de formas de administración. Este dispositivo comprende bolsitas de medicamento dispuestas en una pila de bolsitas con Arzneimittel-Wafernobleas de medicamento und y presenta las siguientes características: a) el dispositivo presenta paralelamente a un borde de las bolsitas de medicamento 1 un portador 9, en el que están colocadas indicaciones temporales, b) en cada una de las bolsitas de medicamento 1 está colocada una marca 20 de modo que las marcas 20 colocadas en las bolsitas de medicamento 1 que siguen en la pila de bolsitas se alinean con indicaciones temporales sucesivas. De esta manera, se garantiza un control de la ingesta de las obleas.To control the intake of medications that are present in the form of wafers, a device is created that is appropriate for preserving and making this type of administration available. This device comprises medication sachets arranged in a stack of sachets with Arzneimittel-Wafernobleas de medicara und and has the following characteristics: a) the device has a carrier 9 parallel to an edge of the medicine sachets 1, in which indications are placed temporary, b) on each of the medicine bags 1 a mark 20 is placed so that the marks 20 placed on the medicine bags 1 that follow in the bag of bags are aligned with successive temporary indications. In this way, a control of the intake of the wafers is guaranteed.
CU20100023A2010-02-052010-02-05
DEVICE FOR PRESERVING AND PUTTING OUT OF OBLEAS OF MEDICINAL PRODUCT
CU23605A3
(en)
Pharmaceutical dosage form with breaking strength of at least 500 n, containing an active ingredient, 5 to 70% by weight of an inorganic salt, at least 30% by weight of a polyalkylene oxide, wherein the active ingredient is integrated in a controlled release matrix comprising inorganic salt and polyalkylene oxide.
Break-resistant pharmaceutical dosage form comprising a) a pharmacologically active ingredient, b) a polymer, c) a polyalkylene oxide, where a) is present in a controlled release matrix comprising b) and c).
DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDE, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES